Shareholder Rights

Quantum BioPharma Completes Warrant Expiration, Confirms CVR Distribution Date for Potential Litigation Windfall

Quantum BioPharma Completes Warrant Expiration, Confirms CVR Distribution Date for Potential Litigation Windfall

Quantum BioPharma has finalized the expiration of hedge fund warrants and confirmed the record date for contingent value rights that could provide shareholders with a significant share of potential proceeds from its $700 million litigation.

October 21, 2025
Quantum BioPharma Ltd. Announces Special Dividend Linked to Litigation Proceeds

Quantum BioPharma Ltd. Announces Special Dividend Linked to Litigation Proceeds

Quantum BioPharma Ltd. (NASDAQ: QNTM) plans to issue a special dividend in the form of Contingent Value Rights (CVRs) to its Class B Subordinate Voting Shareholders, tied to the outcome of a $700 million+ litigation against several banks for alleged stock manipulation.

June 13, 2025